S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

UnitedHealth Group Stock Forecast, Price & News

+3.35 (+1.02 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $332.22
50-Day Range
MA: $339.24
52-Week Range
Now: $332.22
Volume5.39 million shs
Average Volume3.48 million shs
Market Capitalization$315.22 billion
P/E Ratio19.08
Dividend Yield1.52%
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
UnitedHealth Group logo

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
Year FoundedN/A



Sales & Book Value

Annual Sales$242.16 billion
Cash Flow$17.10 per share
Book Value$63.79 per share


Net Income$13.84 billion


Market Cap$315.22 billion
Next Earnings Date4/21/2021 (Estimated)


Overall MarketRank

2.86 out of 5 stars

Medical Sector

2nd out of 1,960 stocks

Hospital & Medical Service Plans Industry

1st out of 11 stocks

Analyst Opinion: 3.4Community Rank: 3.4Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
+3.35 (+1.02 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive UNH News and Ratings via Email

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

UnitedHealth Group (NYSE:UNH) Frequently Asked Questions

Is UnitedHealth Group a buy right now?

21 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 5 hold ratings, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UnitedHealth Group stock.
View analyst ratings for UnitedHealth Group
or view top-rated stocks.

What stocks does MarketBeat like better than UnitedHealth Group?

Wall Street analysts have given UnitedHealth Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but UnitedHealth Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is UnitedHealth Group's next earnings date?

UnitedHealth Group is scheduled to release its next quarterly earnings announcement on Wednesday, April 21st 2021.
View our earnings forecast for UnitedHealth Group

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Incorporated (NYSE:UNH) released its quarterly earnings results on Tuesday, January, 19th. The healthcare conglomerate reported $2.52 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.39 by $0.13. The healthcare conglomerate earned $65.47 billion during the quarter, compared to analysts' expectations of $64.98 billion. UnitedHealth Group had a net margin of 6.62% and a trailing twelve-month return on equity of 27.53%. The business's quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.90 EPS.
View UnitedHealth Group's earnings history

How has UnitedHealth Group's stock price been impacted by COVID-19?

UnitedHealth Group's stock was trading at $277.78 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, UNH shares have increased by 19.6% and is now trading at $332.22.
View which stocks have been most impacted by COVID-19

How often does UnitedHealth Group pay dividends? What is the dividend yield for UnitedHealth Group?

UnitedHealth Group announced a quarterly dividend on Wednesday, February 24th. Stockholders of record on Monday, March 15th will be given a dividend of $1.25 per share on Tuesday, March 23rd. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Friday, March 12th.
View UnitedHealth Group's dividend history

Is UnitedHealth Group a good dividend stock?

UnitedHealth Group pays an annual dividend of $5.00 per share and currently has a dividend yield of 1.52%. UnitedHealth Group has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of UnitedHealth Group is 33.09%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 27.58% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.
View UnitedHealth Group's dividend history.

What guidance has UnitedHealth Group issued on next quarter's earnings?

UnitedHealth Group issued an update on its FY21 earnings guidance on Wednesday, January, 20th. The company provided EPS guidance of $17.75-18.25 for the period, compared to the Thomson Reuters consensus estimate of $18.19.

What price target have analysts set for UNH?

21 Wall Street analysts have issued 12 month price targets for UnitedHealth Group's shares. Their forecasts range from $330.00 to $454.00. On average, they expect UnitedHealth Group's stock price to reach $387.82 in the next twelve months. This suggests a possible upside of 16.7% from the stock's current price.
View analysts' price targets for UnitedHealth Group
or view top-rated stocks among Wall Street analysts.

Who are UnitedHealth Group's key executives?

UnitedHealth Group's management team includes the following people:
  • Mr. David Scott Wichmann, CEO & Director (Age 58, Pay $6.09M)
  • Sir Andrew Philip Witty, Group Pres (Age 56, Pay $4.03M)
  • Mr. John F. Rex, Exec. VP & CFO (Age 59, Pay $3.63M)
  • Ms. Marianne D. Short, Strategic Advisor (Age 69, Pay $2.46M)
  • Mr. Dirk C. McMahon, Exec. VP & CEO of UnitedHealthcare (Age 61, Pay $3.47M)
  • Mr. Thomas Edward Roos, Sr. VP & Chief Accounting Officer (Age 48)
  • Mr. Philip G.J. McKoy, Chief Information Officer (Age 48)
  • Mr. Ken Ehlert, Chief Scientific Officer & Member of Office of the Chief Exec.
  • Mr. Matthew W. Friedrich, Exec. VP & Chief Legal Officer (Age 53)
  • Ms. Jennifer M. Whitlow, Sr. VP & Chief Communications Officer (Age 48)

What is Dave Wichmann's approval rating as UnitedHealth Group's CEO?

1,269 employees have rated UnitedHealth Group CEO Dave Wichmann on Glassdoor.com. Dave Wichmann has an approval rating of 78% among UnitedHealth Group's employees.

Who are some of UnitedHealth Group's key competitors?

What other stocks do shareholders of UnitedHealth Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other UnitedHealth Group investors own include NVIDIA (NVDA), Visa (V), The Walt Disney (DIS), Johnson & Johnson (JNJ), The Home Depot (HD), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), Mastercard (MA), Intel (INTC) and salesforce.com (CRM).

What is UnitedHealth Group's stock symbol?

UnitedHealth Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "UNH."

Who are UnitedHealth Group's major shareholders?

UnitedHealth Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.55%), FMR LLC (5.54%), Price T Rowe Associates Inc. MD (4.01%), Alliancebernstein L.P. (1.21%), Northern Trust Corp (1.21%) and Clearbridge Investments LLC (1.11%). Company insiders that own UnitedHealth Group stock include D Ellen Wilson, David S Wichmann, Frederick William Mcnabb III, Gail R Wilensky, John F Rex, Marianne D Short, Richard T Burke, Stephen J Hemsley, Thomas E Roos, Timothy Patrick Flynn and William C Ballard Jr.
View institutional ownership trends for UnitedHealth Group

Which institutional investors are selling UnitedHealth Group stock?

UNH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Dodge & Cox, Lone Pine Capital LLC, Egerton Capital UK LLP, Longview Partners Guernsey LTD, Winslow Capital Management LLC, Clearbridge Investments LLC, and Sumitomo Mitsui Trust Holdings Inc.. Company insiders that have sold UnitedHealth Group company stock in the last year include John F Rex, Marianne D Short, Richard T Burke, Stephen J Hemsley, and Thomas E Roos.
View insider buying and selling activity for UnitedHealth Group
or view top insider-selling stocks.

Which institutional investors are buying UnitedHealth Group stock?

UNH stock was bought by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Price T Rowe Associates Inc. MD, Morgan Stanley, Alliancebernstein L.P., Wells Fargo & Company MN, Sanders Capital LLC, Nuveen Asset Management LLC, and Veritas Investment Partners UK Ltd.. Company insiders that have bought UnitedHealth Group stock in the last two years include David S Wichmann, Frederick William Mcnabb III, and Timothy Patrick Flynn.
View insider buying and selling activity for UnitedHealth Group
or or view top insider-buying stocks.

How do I buy shares of UnitedHealth Group?

Shares of UNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UnitedHealth Group's stock price today?

One share of UNH stock can currently be purchased for approximately $332.22.

How much money does UnitedHealth Group make?

UnitedHealth Group has a market capitalization of $315.22 billion and generates $242.16 billion in revenue each year. The healthcare conglomerate earns $13.84 billion in net income (profit) each year or $15.11 on an earnings per share basis.

How many employees does UnitedHealth Group have?

UnitedHealth Group employs 325,000 workers across the globe.

What is UnitedHealth Group's official website?

The official website for UnitedHealth Group is www.unitedhealthgroup.com.

Where are UnitedHealth Group's headquarters?

UnitedHealth Group is headquartered at 9900 BREN ROAD EAST, MINNETONKA MN, 55343.

How can I contact UnitedHealth Group?

UnitedHealth Group's mailing address is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. The healthcare conglomerate can be reached via phone at 952-936-1300 or via email at [email protected]

This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.